(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 6. Dpr immunoprecipitation, localization and activation of Wnt/ß-catenin
target genes. (A) Dpr1-myc and (B) Dpr2-myc immunoprecipitate with Dvl2-HA
from Xenopus lysates. (C) Dpr1-myc and (D) Dpr2-myc localization in
Xenopus animal caps. Small arrow in D indicates nuclear staining.
Large arrow indicates membrane staining. Scale bar: 20 µm in C,D. (E)
Injection of 4 ng dpr1 RNA induces ß-catenin target genes, but 4
ng dpr2 RNA does not. (F) Dpr1 and Dpr2 synergize with suboptimal
dose of zebrafish Dvl2. dpr1 and dpr2 low dose is 0.25 ng,
medium dose is 0.5 ng and high dose is 1.0 ng. ß-galactosidase
RNA dose is 1.0 ng. (G) Dpr1 and Dpr2 with internal control ß-gal in TnT
reaction (upper). Dpr1-myc and Dpr2-myc western from Xenopus lysates
with internal control GFP (lower). (H) Dpr1-Dvl2 synergy is inhibited by Axin.
(I) Dpr1 and Dpr2 do not inhibit Wnt8 activation of ß-catenin target
genes. (J) Dpr1 and Dpr2 synergize with Dvl2 in activating a
ß-catenin-dependent luciferase reporter in HEK 293T cells. The experiment
is representative of three independent transfections, with each data point
being conducted in triplicate. Unless noted otherwise, 1 ng of dpr1-myc,
dpr2-myc and ß-galactosidase RNA, and 0.4 ng dvl2
RNA were used. For I, 1 pg of wnt8 RNA, and 4 ng of dpr1 and
dpr2 RNA were used. For J, 400 ng of Dpr1, Dpr2 or
ß-galactosidase, and 20 ng of zebrafish Dvl2 were transfected. AU,
arbitrary light units.